COVID-19

Ivermectin Ongoing Oxford Trial

What’s your Reaction?

LeftNeutralRight

International Standard Randomised Controlled Trial

Professor Chris Butler, from the University Oxford’s Nuffield Department of Primary Care Health Sciences, Joint Chief Investigator of the PRINCIPLE trial, said, ‘Ivermectin is readily available globally, has been in wide use for many other infectious conditions so it’s a well-known medicine with a good safety profile, and because of the early promising results in some studies it is already being widely used to treat COVID-19 in several countries.

International Standard Randomised Controlled Trial Number ISRCTN86534580

When is the study starting and how long is it expected to run for?

March 2020 to September 2022

What’s your Reaction?

LeftNeutralRight

Click to comment

Leave a Reply

Your email address will not be published.

To Top